Recent Analysts’ Ratings Changes for Ryan Specialty (RYAN)

Posted by on Jul 29th, 2026

Ryan Specialty (NYSE: RYAN) has recently received a number of price target changes and ratings updates:

  • 7/15/2026 – Ryan Specialty was given a new $69.00 price target by Atlantic Securities.
  • 7/15/2026 – Ryan Specialty had its price target raised by Piper Sandler from $40.00 to $44.00. They now have a “neutral” rating on the stock.
  • 7/13/2026 – Ryan Specialty had its price target raised by JPMorgan Chase & Co. from $37.00 to $39.00. They now have an “underweight” rating on the stock.
  • 7/9/2026 – Ryan Specialty had its price target raised by Cantor Fitzgerald from $33.00 to $34.00. They now have a “neutral” rating on the stock.
  • 7/9/2026 – Ryan Specialty had its price target raised by Cantor Fitzgerald from $33.00 to $34.00. They now have a “neutral” rating on the stock.
  • 7/9/2026 – Ryan Specialty had its price target raised by Wells Fargo & Company from $31.00 to $39.00. They now have an “equal weight” rating on the stock.
  • 7/9/2026 – Ryan Specialty had its price target raised by Mizuho from $35.00 to $39.00. They now have a “neutral” rating on the stock.
  • 7/9/2026 – Ryan Specialty was downgraded by Wolfe Research from “outperform” to “peer perform”.
  • 7/8/2026 – Ryan Specialty had its price target lowered by UBS Group AG from $52.00 to $50.00. They now have a “buy” rating on the stock.
  • 7/8/2026 – Ryan Specialty had its price target raised by Keefe, Bruyette & Woods from $44.00 to $48.00. They now have an “outperform” rating on the stock.
  • 7/7/2026 – Ryan Specialty had its price target raised by Barclays PLC from $39.00 to $46.00. They now have an “overweight” rating on the stock.
  • 7/6/2026 – Ryan Specialty had its price target raised by Morgan Stanley from $39.00 to $42.00. They now have an “overweight” rating on the stock.
  • 7/1/2026 – Ryan Specialty had its price target raised by The Goldman Sachs Group, Inc. from $35.00 to $40.00. They now have a “neutral” rating on the stock.
  • 6/30/2026 – Ryan Specialty was upgraded by Zacks Research from “strong sell” to “hold”.
  • 6/9/2026 – Ryan Specialty had its price target raised by UBS Group AG from $51.00 to $52.00. They now have a “buy” rating on the stock.
  • 6/8/2026 – Ryan Specialty was downgraded by The Goldman Sachs Group, Inc. from “buy” to “neutral”. They now have a $35.00 price target on the stock, down from $42.00.

Ryan Specialty Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were issued a dividend of $0.13 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.1%. Ryan Specialty’s dividend payout ratio is currently 67.53%.

Insider Activity

In other news, Director John W. Rogers, Jr. acquired 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was acquired at an average cost of $35.16 per share, with a total value of $263,700.00. Following the acquisition, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. This represents a 6.79% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Mark Stephen Katz bought 3,215 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average price of $31.07 per share, for a total transaction of $99,890.05. Following the acquisition, the executive vice president directly owned 4,332 shares in the company, valued at approximately $134,595.24. This trade represents a 287.82% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 130,715 shares of company stock valued at $4,263,590. Insiders own 52.03% of the company’s stock.

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

See Also

Receive News & Ratings for Ryan Specialty Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.